Russian envoy says relations with NATO started deteriorating long before Ukrainian crisisWorld December 08, 4:55
Contact Group agrees to settle water cuts issue in Lugansk within 7 days ― OSCE envoyWorld December 08, 2:58
Glencore expects deal on purchasing stake in Rosneft to close in mid-DecemberBusiness & Economy December 08, 2:03
Italian Prime Minister Renzi officially resignsWorld December 08, 1:27
43 ceasefire violations reported in Syria in 24 hours ― Russian Defense MinistryWorld December 08, 1:16
One reconciliation agreement signed in Syria in 24 hours ― Russian Defense MinistryWorld December 08, 0:26
Lavrov confirms to Kerry Russia backs US proposal on Aleppo from December 2Russian Politics & Diplomacy December 07, 23:57
Russia has never imposed its decisions on Syria, Assad saysWorld December 07, 23:45
Rosneft privatization deal is completed — KremlinBusiness & Economy December 07, 21:06
GENEVA, January 5. /TASS/. The number of people killed by the Ebola virus has reached 8,153, the World Health Organization (WHO) said in a statement Monday.
A total of 20,656 cases of the Ebola virus disease (EVD) have been reported, the report said. The data refer to Guinea, Liberia and Sierra Leone.
In line with statistics, the maximum number of Ebola-related deaths and cases has been registered in Liberia — 3,471 cumulative deaths and 8,018 cumulative cases. Liberia is followed by Sierra Leone (2,915 deaths and 9,772 cases) and Guinea (1,767 and 2,769 respectively).
Separate cases have also been registered in Mali, Nigeria, Senegal, Spain, Britain and the United States.
The Ebola virus disease, previously known as the Ebola hemorrhagic fever, is a severe illness in humans, often fatal, according to the WHO. The virus is passed on to people from wild animals and can be transmitted from humans to humans. The average EVD case death rate is some 50%
The first outbreaks of the EVD occurred in remote Central African villages, near tropical rainforests. However, major urban and rural areas have been involved in the most recent outbreak in western Africa.
Early supportive care, which includes rehydration and symptomatic treatment, improves the survival rate.
No licensed treatment has yet been proven to be able to neutralize the virus but a number of blood, immunological and drug medications are under development. There are no licensed Ebola vaccines yet but two candidates are being evaluated.